Top Clinical Trials companies in China by Receivables
China
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 510.63 M
|
Dec. 31, 2023 | USD 3.70 | -0.36% |
|
China |
|
| 2 |
USD 93.59 M
|
Dec. 31, 2023 | USD 2.18 | 5.57% |
|
China |
|
| 3 |
USD 81.70 M
|
Dec. 31, 2023 | USD 0.15 | 2.66% |
|
China |
|
| 4 |
USD 65.33 M
|
Dec. 31, 2023 | USD 2.63 | -0.26% |
|
China |
|
| 5 |
USD 59.22 M
|
Dec. 31, 2023 | USD 1.76 | 1.76% |
|
China |
|
| 6 |
USD 52.32 M
|
Dec. 31, 2023 | USD 0.45 | 3.81% |
|
China |
|
| 7 |
USD 47.90 M
|
Dec. 31, 2023 | USD 1.12 | 3.67% |
|
China |
|
| 8 |
USD 41.63 M
|
Dec. 31, 2023 | USD 7.68 | -4.49% |
|
China |
|
| 9 |
USD 23.64 M
|
Dec. 31, 2023 | USD 6.58 | 0.30% |
|
China |
|
| 10 |
USD 20.55 M
|
Dec. 31, 2023 | USD 4.49 | -4.91% |
|
China |
|
| 11 |
USD 19.82 M
|
Dec. 31, 2023 | USD 0.24 | 0.51% |
|
China |
|
| 12 |
USD 16.32 M
|
Dec. 31, 2023 | USD 1.15 | 1.11% |
|
China |
|
| 13 |
USD 8.62 M
|
Dec. 31, 2023 | USD 0.93 | 0.35% |
|
China |
|
| 14 |
USD 5.32 M
|
Dec. 31, 2023 | USD 0.37 | 3.22% |
|
China |
|
| 15 |
USD 3.94 M
|
Dec. 31, 2023 | USD 3.88 | -0.18% |
|
China |
|
| 16 |
USD 1.32 M
|
Dec. 31, 2023 | USD 0.19 | 4.98% |
|
China |
|
| 17 |
USD 1.00 M
|
Dec. 31, 2023 | USD 0.42 | 0.29% |
|
China |
|
| 18 |
USD 356.98 K
|
Dec. 31, 2023 | USD 1.06 | 0.95% |
|
China |
|
| 19 |
USD 222.03 K
|
Dec. 31, 2023 | USD 1.85 | NA |
|
China |
|
| 20 |
USD 137.89 K
|
Dec. 31, 2023 | USD 0.20 | 3.38% |
|
China |
|
| 21 |
USD 51.00 K
|
Dec. 31, 2023 | USD 0.97 | NA |
|
China |
|
| 22 |
USD 5.49 K
|
Dec. 31, 2023 | USD 0.66 | -1.16% |
|
China |
|
| 23 |
USD 22.68
|
Dec. 31, 2023 | USD 0.73 | 0.16% |
|
China |
|
| 24 |
USD 0.00
|
Dec. 31, 2023 | USD 0.18 | 1.43% |
|
China |
Frequently Asked Questions
-
Which Clinical Trials company in China has the highest Receivables ?
The Clinical Trials company in China with the highest Receivables is Hangzhou Tigermed Consulting Co., Ltd. (HKSE: 3347.HK) at USD 510.63 M.
-
Which Clinical Trials company in China has the lowest Receivables ?
The Clinical Trials company in China with the lowest Receivables is JW (Cayman) Therapeutics Co. Ltd (HKSE: 2126.HK) at USD 0.00.
-
What are the top 10 Clinical Trials companies in China by Receivables ?
The top 10 Clinical Trials companies in China by Receivables are Hangzhou Tigermed Consulting Co., Ltd., Shanghai Henlius Biotech, Inc., Kindstar Globalgene Technology, Inc., Zai Lab Limited, RemeGen Co., Ltd., HBM Holdings Limited, Joinn Laboratories(China)Co.,Ltd., Akeso, Inc., Burning Rock Biotech Limited and Ascentage Pharma Group International.
-
What are the bottom 10 Clinical Trials companies in China by Receivables ?
The bottom 10 Clinical Trials companies in China by Receivables are JW (Cayman) Therapeutics Co. Ltd, InnoCare Pharma Limited, ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Connect Biopharma Holdings Limited, Hua Medicine (Shanghai) Ltd., Adagene Inc., I-Mab, Alphamab Oncology, Jacobio Pharmaceuticals Group Co., Ltd. and Keymed Biosciences Inc..
